🚨 NEWS 🚨 European Commission grants conditional marketing authorization to linvoseltamab for the treatment of RRMM with ≥3 prior therapies, including an IMiD, PI, and anti-CD38 antibody, with progression on the last therapy. loom.ly/79GKMAs #mmsm #myeloma #MedNews #MedEd

Administration of lenalidomide continuously for six or more cycles shows meaningful efficacy in patients with relapsed or refractory multiple #myeloma without serious toxicity, according to a phase 1b study presented at #AACR25. 📰 Read more: buff.ly/SyAMkaa

Excited to announce the inaugural annual meeting for the Irish Myeloma Society (IMMS) on 12th September 2025 at the Gibson Hotel, Dublin! We are delighted to be featuring an excellent programme of national and international speakers. More details to follow.

📣 Attention Haematology Clinicians and Multiple Myeloma researchers! 🚨 Submissions are NOW OPEN for abstract and poster competition at the Inaugural Irish Multiple Myeloma Society Meeting in Dublin on 12th September 2025! Clinical and scientific abstracts welcome 🧪🩸

📣 Join us on September 12th 2025 for the Inaugural Annual Meeting of the Irish Multiple Myeloma Society (IMMS)! A day of clinical & research insights with international leaders in the field 🧬🩸 eventbrite.ie/e/irish-multip…

Irish Life Dublin Marathon Myeloma Society Multiple Myeloma RF Beaumont RCSI Cancer Centre

Two of our IITs in Multiple Myeloma, 19-17 CPD Dara and 19-34 Isa RVD, have been submitted for consideration at the 67th ASH Annual Meeting. Huge thanks to all involved. Your teamwork made it possible. #ASH25 #CancerTrials #Haematology #Teamwork

📣 DEADLINE EXTENDED: Abstract and poster competition submissions are open for the inaugural IMMS meeting 🩸. Clinical and scientific abstracts related to multiple myeloma and all plasma cell disorders are eligible. 🧬 Submit abstracts to: [email protected] 📣